Peter Seidler is the Chief Administrative Officer at Cognigenics, a leading organization in cognitive genetics that creates RNA therapeutics for mental health. Throughout his career, Seidler has created and built organizations that connect advanced scientific research with practical solutions to benefit the human experience. Seidler highlights a ground-breaking approach to mental health in his work, emphasizing the interplay between genetics, brain functions, and consciousness.
Peter Seidler’s 'Cognitive Genetics' explores how genetic engineering and RNA therapeutic advancements could transform how we treat mental health and memory challenges. The book bridges cutting-edge science with accessible insights to improve people’s lives. Featuring a foreword by scientist Dean Radin, PhD, 'Cognitive Genetics' highlights the exciting possibilities for mental health and cognitive well-being.
This innovative approach to brain health addresses the underlying dysregulation of mental and emotional imbalances. By combining precise genetic tools with a broader understanding of how brain networks function, this strategy offers more effective and personalized interventions than traditional methods.
Recent developments in genetic engineering—such as CRISPR, RNA-based therapies, and artificial intelligence—have reshaped what’s possible in medical science. For example, in preclinical studies, RNA-based treatments can precisely target interventions for anxiety and memory decline. Cognigenics has applied this approach focusing on the limbic system, including the hippocampus, which plays a key role in anxiety and memory retention.
These advancements represent a new frontier in mental health care, blending science and innovation to provide safer, more effective alternatives.